Alligator Bioscience AB (publ) - Laporan Laba Rugi (TTM)

Alligator Bioscience AB (publ)
SE ˙ OM
SEK 4.40 ↑0.18 (4.25%)
2025-09-01
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Alligator Bioscience AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 5 6 6 5 8 13 18 20 21 36 40 53 68 59 56 46 28 58 51 44
Change (%) 3.12 11.19 -21.10 62.59 69.43 35.56 8.70 9.18 67.92 12.37 30.96 27.50 -12.28 -4.67 -18.64 -39.56 107.83 -11.64 -14.22
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 104 82 75 75 82 87 99 110 122 148 169 195 211 219 210 188 182 167 151 143
Change (%) -20.80 -9.05 -0.22 9.58 6.26 14.38 10.82 10.70 21.03 14.43 15.20 8.28 3.75 -3.86 -10.51 -3.26 -8.18 -9.62 -5.44
% of Revenue 1,943.47 1,492.66 1,220.91 1,544.05 1,040.64 652.68 550.69 561.42 569.28 410.34 417.87 367.60 312.20 369.26 372.42 409.63 655.68 289.67 296.31 326.67
Gross Operating Profit -99 -77 -69 -70 -74 -74 -81 -91 -101 -112 -129 -142 -143 -160 -154 -142 -154 -109 -100 -99
Change (%) -22.10 -10.51 1.64 5.91 -0.45 10.55 11.29 11.03 11.04 15.10 10.25 1.10 11.31 -3.56 -7.53 8.47 -29.06 -8.55 -0.96
% of Revenue -1,843.47 -1,392.66 -1,120.91 -1,444.05 -940.64 -552.68 -450.69 -461.42 -469.28 -310.34 -317.87 -267.60 -212.20 -269.26 -272.42 -309.63 -555.68 -189.67 -196.31 -226.67
SG&A 59 56 53 51 54 57 59 63 65 69 72 75 76 79 82 78 77 70 69 59
Change (%) -5.53 -5.23 -3.60 5.53 5.84 3.78 6.45 3.19 6.21 4.28 4.98 1.38 3.90 3.33 -4.84 -0.95 -8.90 -2.35 -14.62
% of Revenue 1,102.64 1,010.15 861.04 1,052.09 682.88 426.61 326.60 319.83 302.29 191.21 177.43 142.24 113.10 133.97 145.21 169.85 278.36 122.01 134.84 134.22
R&D
Change (%)
% of Revenue
OpEx 174 150 138 136 146 155 170 183 199 228 252 283 300 309 303 276 268 286 264 232
Change (%) -13.90 -7.73 -1.39 7.26 6.18 9.84 7.59 8.43 14.96 10.52 12.30 5.70 3.05 -1.79 -8.93 -3.01 6.92 -7.66 -12.36
% of Revenue 3,247.79 2,711.71 2,250.41 2,812.79 1,855.59 1,162.89 942.27 932.67 926.27 634.16 623.73 534.85 443.42 520.90 536.67 600.71 963.96 495.90 518.27 529.56
Operating Income -168 -144 -132 -131 -138 -142 -152 -164 -177 -192 -212 -230 -232 -249 -247 -230 -240 -229 -213 -188
Change (%) -14.44 -8.45 -0.47 5.22 2.58 7.42 7.46 8.34 8.55 10.18 8.73 0.69 7.51 -1.10 -6.71 4.29 -4.76 -6.65 -11.91
% of Revenue -3,147.79 -2,611.71 -2,150.41 -2,712.79 -1,755.59 -1,062.89 -842.27 -832.67 -826.27 -534.16 -523.73 -434.85 -343.42 -420.90 -436.67 -500.71 -863.96 -395.90 -418.27 -429.56
Interest Expense -3 -0 -2 -2 -2 -0 -0 -0 -1 -1 -1 -1 -0 -4 -6 -10 -20 -30 -45
Change (%) -87.99 636.42 5.38 -17.33 -88.50 -44.59 345.52 33.13 33.72 -4.87 -55.85 694.41 53.66 77.09 88.58 51.63 51.11
% of Revenue -48.75 -5.68 -37.59 -50.21 -25.53 -1.73 -0.71 -0.68 -1.79 -2.13 -2.17 -1.62 -0.82 -6.79 -12.83 -37.59 -34.11 -58.54 -103.12
Net Income -169 -143 -133 -133 -139 -142 -152 -163 -177 -193 -213 -231 -232 -249 -249 -234 -248 -234 -179 -132
Change (%) -14.98 -7.08 -0.07 4.81 1.63 7.29 7.07 8.67 9.30 10.07 8.46 0.49 7.15 0.08 -5.83 5.98 -5.81 -23.26 -26.48
% of Revenue -3,151.53 -2,598.30 -2,171.51 -2,750.39 -1,772.97 -1,063.53 -841.75 -829.12 -825.29 -537.22 -526.20 -435.79 -343.48 -419.55 -440.49 -509.86 -894.02 -405.19 -351.92 -301.65

Source: Capital IQ

Other Listings
DE:7AL0
GB:0RK9
GB:ATORXS
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista